Filing Details
- Accession Number:
- 0001562180-18-004822
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2018-12-04 18:10:59
- Reporting Period:
- 2018-12-04
- Accepted Time:
- 2018-12-04 18:10:59
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1560241 | G1 Therapeutics Inc. | GTHX | () | 4 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1184420 | Seth Rudnick | C/O G1 Therapeutics, Inc. 79 T.w. Alexander Drive Research Triangle Park NC 27709 | No | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2018-12-04 | 607 | $0.39 | 607 | No | 4 | M | Direct | |
| Common Stock | Acquisiton | 2018-12-04 | 9,393 | $0.39 | 10,000 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2018-12-04 | 9,884 | $39.31 | 116 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2018-12-04 | 116 | $40.00 | 0 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Options (Right to Buy) | Disposition | 2018-12-04 | 607 | $0.00 | 607 | $0.39 |
| Common Stock | Stock Options (Right to Buy) | Disposition | 2018-12-04 | 9,393 | $0.00 | 9,393 | $0.39 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 0 | 2024-01-21 | No | 4 | M | Direct | |
| 7,969 | 2024-07-11 | No | 4 | M | Direct |
Reported Non-Derivative Holdings
| Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
|---|---|---|---|
| Common Stock | 58,282 | Indirect | See Footnote |
Footnotes
- The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan.
- The price represents the weighted average price with a low of $38.99 and a high of $39.545. The Reporting Person undertakes to provide G1 Therapeutics, Inc., any security holder of G1 Therapeutics, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote 2 to this Form 4.
- These shares are held in the Seth A. Rudnick 2014 GST Trust U/A Dated 03/01/2014 (the "Trust") for the benefit of the Reporting Person's heirs. The Reporting Person's spouse is trustee of the Trust. The Reporting Person disclaims beneficial ownership of these securities, and this report shall not be deemed an admission that the Reporting Person is the beneficial owner of such securities for purposes of Section 16 or for any other purpose.
- All shares underlying this option have vested.
Billionaire Hedge Funds
